An MHRA accredited Manufacturing Facility based in Maidenhead, UK.
Noumed’s manufacturing facility has the capability to manufacture various solid dosage forms which include plain and coated tablets, and hard gelatin capsules. The facility is equipped with R & D suites to aid New Product development, undertaking feasibility and optimization trials and for manufacturing small batches for clinical trials etc.
All production takes place in isolated ISO-Class 8 / Class D certified rooms in accordance with cGMP and FDA guidelines. Additionally, all airflows are regulated through the use of airlocks and pressure differentials.
Manufacturing is supported with in-process storage areas and material handling equipment to improve efficiency. The facility has 3 suites for tablet manufacturing and 2 suites for capsule manufacturing.
The tablet manufacturing suite has 3 independent granulation areas supported by tablet compression machines and coating pans. The 3 granulation suites are equipped with a Vacuum Transfer System.
The 2 capsule manufacturing suites are fitted with automatic capsule filling lines.
The manufacturing facility is equipped with a range of cage blenders from 50 litres to 1200 litres, and has a dedicated area for formulation/product development.”
An MHRA accredited manufacturing facility manufactures multiple dosage forms and flexible batch sizes
Quality Control is fitted with high-spec analytical and testing equipment to support manufacturing and development
The fully equipped warehouse has provisions to store materials requiring cold storage conditions. It also has a dedicated area to store controlled substances
The focus on adhering to GMP guidelines and ensuring compliance to regulations, enables us to meet quality, efficacy and safety requirements. Through pharmacovigilance, product performance is regularly monitored to ensure patient safety
Noumed has a network of CMOs in various geographies to manufacture diverse dosage forms in addition to what can be manufactured in-house